Home / Learn / Resource Detail

Key Highlights from an ACCC Survey on Remote Patient Monitoring — [MINI PODCAST] EP 113

May 23, 2023

Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!


Remote patient monitoring is a type of telehealth that allows patients to share data about their health with their care team in between clinic visits, including symptoms and vitals. Symptom tracking and monitoring technologies allow better management of treatment side effects, in turn allowing longer administration of treatments and improved clinical outcomes. While advantages to remote patient monitoring are well-known and documented in the literature, translation into clinical practice must account for patient preferences, equity considerations, financial sustainability, and patient/provider education needs.

In 2022, ACCC conducted a survey to measure patient, caregiver, and provider perceptions and adoption of messaging tools, electronic questionnaires, and connected devices used to track and monitor symptoms during cancer treatment. This podcast shares key survey findings.


David PenberthyDavid Penberthy, MD, MBA
Associate Professor of Radiation Oncology
Penn State Health, Milton S. Hershey Medical Center
Immediate Past President
Association of Community Cancer Centers


"Through the pandemic, healthcare has been contending with workforce shortages, and so everybody is concerned about how we do more with less. Using digital tools can actually help facilitate patient engagement with the healthcare team—hopefully keeping people out of the hospital and intervening earlier so we can achieve more of what we’re trying to achieve of maintaining health as opposed to just reacting to illness."

Read more in the Digital Tools in Cancer Care Survey Results document.


This project is supported by AstraZeneca.

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.